Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | TGM2 | P21980 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 3/20 | 0.48 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | KLK7 | P49862 | 2/20 | 0.47 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.47 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.46 |
| ▸ | SYK | P43405 | 1/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.44 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.44 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12076369 | 1.00 | MAPT (0.52) | MAPTHTTTGM2KEAP1NFE2L2 | |
| SCHEMBL29931085 | 0.95 | HTT (0.54) | MAPTHTTTGM2KEAP1NFE2L2 | |
| SCHEMBL3898159 | 0.91 | MAPT (0.50) | MAPTHTTTGM2KEAP1NFE2L2 | |
| SCHEMBL28745362 | 0.87 | KLK7 (0.43) | MAPTHTTTGM2KEAP1NFE2L2 | |
| SCHEMBL28745361 | 0.87 | KLK7 (0.43) | MAPTHTTTGM2KEAP1NFE2L2 | |
| SCHEMBL8574384 | 0.87 | MAPT (0.47) | MAPTHTTTGM2KEAP1NFE2L2 | |
| SCHEMBL8574390 | 0.87 | MAPT (0.47) | MAPTHTTTGM2KEAP1NFE2L2 | |
| SCHEMBL31300270 | 0.86 | MAPT (0.52) | MAPTHTTTGM2KEAP1NFE2L2 | |
| SCHEMBL29396217 | 0.86 | HTT (0.56) | MAPTHTTTGM2KEAP1NFE2L2 | |
| SCHEMBL13480435 | 0.83 | MAPT (0.65) | MAPTHTTTGM2KEAP1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230183253-A1 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | RHODE ISLAND HOSPITAL | 2023-06-15 | — | — | US | disclosed |
| US-11608340-B2 | Nanomaterial compositions, synthesis, and assembly | RHODE ISLAND HOSPITAL (US) | 2023-03-21 | — | — | US | disclosed |
| EP-3804725-A2 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | Rhode Island Hospital (US) | 2021-04-14 | — | — | EP | disclosed |
| EP-3220914-B1 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | RHODE ISLAND HOSPITAL (US) | 2020-09-02 | — | — | EP | disclosed |
| US-20170362238-A1 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | RHODE ISLAND HOSPITAL | 2017-12-21 | — | — | US | disclosed |
| EP-3220914-A1 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | Rhode Island Hospital (US) | 2017-09-27 | — | — | EP | disclosed |
| WO-2016081522-A1 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | RHODE ISLAND HOSPITAL (US) | 2016-05-26 | — | — | WO | disclosed |
| US-20050131230-A1 | Method and associated compounds for forming nanotubes | NATIONAL SCIENCE FOUNDATION | 2005-06-16 | — | — | US | disclosed |
| US-6696565-B2 | SELF-ASSEMBLING; PHYSICAL PROPERTIES; THERMOCONDUCTIVITY | PURDUE RESEARCH FOUNDATION | 2004-02-24 | — | — | US | disclosed |
| US-20020151556-A1 | Method and associated compounds for forming nanotubes | PURDUE RESEARCH FOUNDATION | 2002-10-17 | — | — | US | disclosed |
| WO-2002066482-A1 | METHOD AND ASSOCIATED COMPOUNDS FOR FORMING NANOTUBES | PURDUE RESEARCH FOUNDATION (US) | 2002-08-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050131230-A1 | Method and associated compounds for forming nanotubes | TUBB6, TUBB4A, TUBB4B | MAPT 103/4885HTT 437/4885TGM2 1350/4885 |
| US-11608340-B2 | Nanomaterial compositions, synthesis, and assembly | POLRMT, NT5C3B, CHMP4B | MAPT 997/4885HTT 1228/4885TGM2 1303/4885 |
| US-20020151556-A1 | Method and associated compounds for forming nanotubes | TUBB6, TUBB4A, TUBB4B | MAPT 103/4885HTT 437/4885TGM2 1350/4885 |
| US-20170362238-A1 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | POLRMT, NT5C3B, CHMP4B | MAPT 997/4885HTT 1228/4885TGM2 1303/4885 |
| US-20230183253-A1 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | POLRMT, NT5C3B, CHMP4B | MAPT 997/4885HTT 1228/4885TGM2 1303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.